131 related articles for article (PubMed ID: 11233297)
1. [Advanced findings on the molecular mechanisms for behavioral sensitization to psychostimulants].
Ujike H
Nihon Yakurigaku Zasshi; 2001 Jan; 117(1):5-12. PubMed ID: 11233297
[TBL] [Abstract][Full Text] [Related]
2. Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine.
Wang YM; Gainetdinov RR; Fumagalli F; Xu F; Jones SR; Bock CB; Miller GW; Wightman RM; Caron MG
Neuron; 1997 Dec; 19(6):1285-96. PubMed ID: 9427251
[TBL] [Abstract][Full Text] [Related]
3. Gene expression related to synaptogenesis, neuritogenesis, and MAP kinase in behavioral sensitization to psychostimulants.
Ujike H; Takaki M; Kodama M; Kuroda S
Ann N Y Acad Sci; 2002 Jun; 965():55-67. PubMed ID: 12105085
[TBL] [Abstract][Full Text] [Related]
4. [Molecular biology of drug dependence and behavioral sensitization].
Ujike H
Seishin Shinkeigaku Zasshi; 2002; 104(11):1055-68. PubMed ID: 12642909
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of stimulants on monoaminergic transporters: pharmacological consequences and implications for neurotoxicity.
Fleckenstein AE; Gibb JW; Hanson GR
Eur J Pharmacol; 2000 Oct; 406(1):1-13. PubMed ID: 11011026
[TBL] [Abstract][Full Text] [Related]
6. [Involvement of prefrontal serotonergic neurons in methamphetamine-induced behavioral sensitization].
Ago Y; Nakamura S; Arikawa S; Yata M; Matsuda T
Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Apr; 28(2):85-91. PubMed ID: 18516987
[TBL] [Abstract][Full Text] [Related]
7. Differential trafficking of the vesicular monoamine transporter-2 by methamphetamine and cocaine.
Riddle EL; Topham MK; Haycock JW; Hanson GR; Fleckenstein AE
Eur J Pharmacol; 2002 Aug; 449(1-2):71-4. PubMed ID: 12163108
[TBL] [Abstract][Full Text] [Related]
8. Attenuated methamphetamine-induced locomotor sensitization in serotonin transporter knockout mice is restored by serotonin 1B receptor antagonist treatment.
Igari M; Shen HW; Hagino Y; Fukushima S; Kasahara Y; Lesch KP; Murphy DL; Hall FS; Uhl GR; Ikeda K; Yaegashi N; Sora I
Behav Pharmacol; 2015 Feb; 26(1-2):167-79. PubMed ID: 25485646
[TBL] [Abstract][Full Text] [Related]
9. Cocaine mechanisms: enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions.
Hall FS; Li XF; Sora I; Xu F; Caron M; Lesch KP; Murphy DL; Uhl GR
Neuroscience; 2002; 115(1):153-61. PubMed ID: 12401330
[TBL] [Abstract][Full Text] [Related]
10. Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice.
Patel J; Mooslehner KA; Chan PM; Emson PC; Stamford JA
J Neurochem; 2003 May; 85(4):898-910. PubMed ID: 12716422
[TBL] [Abstract][Full Text] [Related]
11. Impact of psychostimulants on vesicular monoamine transporter function.
Fleckenstein AE; Hanson GR
Eur J Pharmacol; 2003 Oct; 479(1-3):283-9. PubMed ID: 14612158
[TBL] [Abstract][Full Text] [Related]
12. Deficits in behavioral sensitization and dopaminergic responses to methamphetamine in adenylyl cyclase 1/8-deficient mice.
Bosse KE; Charlton JL; Susick LL; Newman B; Eagle AL; Mathews TA; Perrine SA; Conti AC
J Neurochem; 2015 Dec; 135(6):1218-31. PubMed ID: 26146906
[TBL] [Abstract][Full Text] [Related]
13. Methamphetamine rapidly decreases mouse vesicular dopamine uptake: role of hyperthermia and dopamine D2 receptors.
Ugarte YV; Rau KS; Riddle EL; Hanson GR; Fleckenstein AE
Eur J Pharmacol; 2003 Jul; 472(3):165-71. PubMed ID: 12871750
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the vesicular monoamine transporter-2: a novel mechanism for cocaine and other psychostimulants.
Brown JM; Hanson GR; Fleckenstein AE
J Pharmacol Exp Ther; 2001 Mar; 296(3):762-7. PubMed ID: 11181904
[TBL] [Abstract][Full Text] [Related]
15. Quantitative changes in Galphaolf protein levels, but not D1 receptor, alter specifically acute responses to psychostimulants.
Corvol JC; Valjent E; Pascoli V; Robin A; Stipanovich A; Luedtke RR; Belluscio L; Girault JA; Hervé D
Neuropsychopharmacology; 2007 May; 32(5):1109-21. PubMed ID: 17063155
[TBL] [Abstract][Full Text] [Related]
16. Differential roles of dopamine D1 and D2 receptor-containing neurons of the nucleus accumbens shell in behavioral sensitization.
Kai N; Nishizawa K; Tsutsui Y; Ueda S; Kobayashi K
J Neurochem; 2015 Dec; 135(6):1232-41. PubMed ID: 26442961
[TBL] [Abstract][Full Text] [Related]
17. Reduced striatal vesicular monoamine transporters after neurotoxic but not after behaviorally-sensitizing doses of methamphetamine.
Frey K; Kilbourn M; Robinson T
Eur J Pharmacol; 1997 Sep; 334(2-3):273-9. PubMed ID: 9369358
[TBL] [Abstract][Full Text] [Related]
18. [Alteration of neuronal activities following repeated administration of stimulants].
Amano T; Matsubayashi H; Sasa M
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2002 Feb; 37(1):31-40. PubMed ID: 11915303
[TBL] [Abstract][Full Text] [Related]
19. Effects of methamphetamine and lobeline on vesicular monoamine and dopamine transporter-mediated dopamine release in a cotransfected model system.
Wilhelm CJ; Johnson RA; Lysko PG; Eshleman AJ; Janowsky A
J Pharmacol Exp Ther; 2004 Sep; 310(3):1142-51. PubMed ID: 15102929
[TBL] [Abstract][Full Text] [Related]
20. Dopamine mediates striatal malonate toxicity via dopamine transporter-dependent generation of reactive oxygen species and D2 but not D1 receptor activation.
Xia XG; Schmidt N; Teismann P; Ferger B; Schulz JB
J Neurochem; 2001 Oct; 79(1):63-70. PubMed ID: 11595758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
